[go: up one dir, main page]

GB201217621D0 - Anticonvulsant activity of gsk-3b inhibitors - Google Patents

Anticonvulsant activity of gsk-3b inhibitors

Info

Publication number
GB201217621D0
GB201217621D0 GBGB1217621.0A GB201217621A GB201217621D0 GB 201217621 D0 GB201217621 D0 GB 201217621D0 GB 201217621 A GB201217621 A GB 201217621A GB 201217621 D0 GB201217621 D0 GB 201217621D0
Authority
GB
United Kingdom
Prior art keywords
gsk
inhibitors
anticonvulsant activity
anticonvulsant
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1217621.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Katholieke Universiteit Leuven
Original Assignee
Katholieke Universiteit Leuven
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Katholieke Universiteit Leuven filed Critical Katholieke Universiteit Leuven
Priority to GBGB1217621.0A priority Critical patent/GB201217621D0/en
Publication of GB201217621D0 publication Critical patent/GB201217621D0/en
Priority to PCT/EP2013/070599 priority patent/WO2014053580A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB1217621.0A 2012-10-02 2012-10-02 Anticonvulsant activity of gsk-3b inhibitors Ceased GB201217621D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1217621.0A GB201217621D0 (en) 2012-10-02 2012-10-02 Anticonvulsant activity of gsk-3b inhibitors
PCT/EP2013/070599 WO2014053580A1 (en) 2012-10-02 2013-10-02 Anticonvulsant activity of gsk-3beta inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1217621.0A GB201217621D0 (en) 2012-10-02 2012-10-02 Anticonvulsant activity of gsk-3b inhibitors

Publications (1)

Publication Number Publication Date
GB201217621D0 true GB201217621D0 (en) 2012-11-14

Family

ID=47225555

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1217621.0A Ceased GB201217621D0 (en) 2012-10-02 2012-10-02 Anticonvulsant activity of gsk-3b inhibitors

Country Status (2)

Country Link
GB (1) GB201217621D0 (en)
WO (1) WO2014053580A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202100006065A1 (en) * 2021-03-15 2022-09-15 Univ Degli Studi Padova COMPOUND FOR USE IN THE METHOD OF TREATMENT OF MITOCHONDRIAL DISEASES DUE TO DYSFUNCTION OF THE RESPIRATORY CHAIN COMPLEX I, II, III
US20240228467A1 (en) * 2021-04-29 2024-07-11 Jawaharlal Nehru Centre For Advanced Scientific Research Indirubin compounds and methods thereof
EP4329747A4 (en) * 2021-04-29 2025-03-19 Jawaharlal Nehru Centre For Advanced Scientific Research Soluble analogues of 6bio thereof and implementation thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2806626B1 (en) * 2000-03-22 2003-11-28 Centre Nat Rech Scient USE OF MODULATING SUBSTANCES FOR THE EXPRESSION OR FUNCTION OF A PROTEIN INVOLVED IN THE CELL CYCLE FOR THE TREATMENT OR PREVENTION OF ACUTE NEURAL INJURIES
CA2522712A1 (en) * 2003-04-18 2004-10-28 Kyowa Hakko Kogyo Co., Ltd. Nerve regenerating drug
AU2004285522A1 (en) * 2003-10-28 2005-05-12 Centre National De La Recherche Scientifique Indirubin-type compounds, compositions, and methods for their use

Also Published As

Publication number Publication date
WO2014053580A1 (en) 2014-04-10

Similar Documents

Publication Publication Date Title
AP4029A (en) Inhibitors of beta-secretase
ZA201504200B (en) Beta-lactamase inhibitors
PT3447052T (en) Methods of preparing new idh1 inhibitors
IL232358A0 (en) Inhibitors of phosphodiesterase type 10a
AP2014007679A0 (en) Use of inhibitors of the activity or function of P13K
ZA201206456B (en) Uses of dgati inhibitors
SG11201400102WA (en) Inhibitors of nedd8-activating enzyme
IL242314A (en) Inhibitors of iap
IL235919A0 (en) Fbxo3 inhibitors
IL236963A0 (en) Inhibitors of beta-secretase
IL236630B (en) Urea compounds and their use as enzyme inhibitors
PL2888228T3 (en) Inhibitors of cd40-traf6 interaction
GB201217621D0 (en) Anticonvulsant activity of gsk-3b inhibitors
EP2879681A4 (en) INDOLE-SUBSTITUTED PYRROLOPYRIMIDINYL INHIBITORS OF Uba6
GB201201857D0 (en) Pseudonymisation/de-pseudonymisation of data
GB201223308D0 (en) Enzyme inhibitors
GB201120474D0 (en) Inhibitors
GB201105579D0 (en) Osteoclast activity
GB201105580D0 (en) Osteoclast activity

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)